These dividend stocks have slashed their payments, Morgan Stanley says

Morgan Stanley says stocks that cut dividends by at least 15% over the past 12 months can recover after an initial selloff, as balance-sheet repair and lower payout obligations improve fundamentals. Healthcare Realty Trust cut its dividend 23% to $0.24 a share last July and now yields 4.7%, while Dow halved its dividend to $0.35 a share and yields 4.2%; both have rallied in 2026, with Healthcare Realty up 20% and Dow up 42%. The backdrop remains rate-sensitive, with the Fed holding rates at 3.5% to 3.75% and higher-for-longer policy plus inflation pressuring leveraged dividend payers.

Analysis

Dividend cuts here are less a “yield story” than a balance-sheet reset trade. The market usually sells first because income mandates and factor screens mechanically eject the names, but the second-order effect is that retained cash starts compounding back into asset quality, refinancing flexibility, and buyback optionality. That creates a delayed re-rating window: the first 3-6 months tend to be about de-rating and index exclusion; months 6-18 are where lower leverage and cleaner capital allocation can drive multiple expansion.

HR looks like the cleanest post-cut recovery candidate because the dividend reset was directly tied to funding internally generated growth and reducing refinancing risk, not to a secular demand collapse. In REITs, the key tell is whether management can defend occupancy and same-store NOI while reducing the weighted average cost of capital gap versus cap rates; if yes, the cut becomes an equity-positive capital reallocation rather than a distress signal. The risk is that higher-for-longer rates keep cap rates elevated, which would cap any valuation rebound even if operations improve.

DOW is more cyclical and therefore less forgiving: the dividend reset buys time, but the stock still depends on industrial demand and feedstock spreads. The geopolitical overlay matters because energy input volatility can temporarily help chemical spread sentiment, but if the macro backdrop weakens or China demand rolls over, the market will see the cut as a sign the peak-cash-flow era is over rather than a reset. The contrarian point is that the most crowded mistake is assuming all dividend cutters are value traps; in levered, asset-heavy businesses, a smaller payout can be the highest-ROIC action available if it prevents forced equity issuance.

Key Decisions for Investors

• Long HR on a 6-12 month horizon; prefer adding on weakness after yield-focused sellers clear. Risk/reward is attractive if management continues to execute on the three-year deleveraging plan and same-store metrics hold, but cut exposure if rates back up and cap-rate compression stalls.
• Long DOW only as a tactical recovery trade, not a core hold; size smaller than HR because cyclicality can override the balance-sheet benefit. Best entry is on macro-driven pullbacks, with a stop if global industrial PMI and chemical spreads deteriorate for two consecutive months.
• Pair trade: long HR / short a higher-leverage REIT with no recent balance-sheet reset and weaker funding access. The thesis is that post-cut REITs with retained cash should outperform peers if financing conditions remain tight over the next 2 quarters.
• Use the dividend-cut universe as a screening basket for long-only accumulation, but avoid names where the cut did not materially reduce leverage or extend maturities. Require at least one hard catalyst: refinance risk reduction, capex-funded growth, or visible margin recovery within 1-2 quarters.
• For more convex exposure, buy 6-9 month call spreads in HR rather than common stock if implied volatility is depressed. The payoff is best if the market begins to price the balance-sheet repair before the next earnings cycle.